Citadel Advisors »

Sensei Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 26k 0.69
2022-06-30 $134k 59k 2.26
2021-09-30 $1.3M 123k 10.52
2021-06-30 $2.8M 284k 9.79
2021-03-31 $10M 693k 14.53

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Sensei Biotherapeutics

Newtyn Management
Vanguard Group
Duquesne Family Office
Bank of America Corporation
Millennium Management
Citadel Advisors
Two Sigma Advisers
Leo Wealth
Raymond James & Associates
Deuterium Capital Management
Two Sigma Investments
Banque Cantonale Vaudoise
Jpmorgan Chase & Co
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Sensei Biotherapeutics